Meridian Bioscience makes James Anderson director
This article was originally published in Clinica
Meridian Bioscience has appointed James Anderson to its board of directors with immediate effect. Mr Anderson has been president and CEO of Cincinnati Children's Hospital Medical Center in Ohio since 1996. Before this, he served on the Cincinnati Children's board for 20 years, including four years as chairman. He has also worked at law firm Taft, Stettinius & Hollister, and Xomox, a manufacturer of speciality process controls. Meridian manufactures, markets and distributes a range of diagnostic test kits, reagents and related products.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.